Jonathan G Howlett

Summary

Publications

  1. pmc Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials
    Jonathan G Howlett
    University of Calgary, Calgary, Alberta
    Can J Cardiol 25:85-105. 2009
  2. pmc End-of-life planning in heart failure: it should be the end of the beginning
    Jonathan Howlett
    University of Calgary, Alberta
    Can J Cardiol 26:135-41. 2010
  3. ncbi request reprint Nebivolol: vasodilator properties and evidence for relevance in treatment of cardiovascular disease
    Jonathan G Howlett
    Department of Medicine, University of Calgary and Libin Cardiovascular Institute, Calgary, Alberta, Canada Electronic address
    Can J Cardiol 30:S29-37. 2014
  4. ncbi request reprint Specialist heart failure clinics must evolve to stay relevant
    Jonathan G Howlett
    Department of Cardiac Sciences, University of Calgary and Libin Cardiovascular Institute, Calgary, Alberta, Canada Electronic address
    Can J Cardiol 30:276-80. 2014
  5. doi request reprint Palliative care in heart failure: addressing the largest care gap
    Jonathan G Howlett
    University of Calgary, 1403 29th Street NW, Calgary, Alberta, Canada
    Curr Opin Cardiol 26:144-8. 2011
  6. pmc The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs
    Jonathan G Howlett
    University of Calgary, Alberta, Canada
    Can J Cardiol 26:185-202. 2010
  7. doi request reprint The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
    Daniel G Hackam
    Division of Clinical Pharmacology, Department of Medicine, Western University, London, Ontario, Canada
    Can J Cardiol 29:528-42. 2013
  8. ncbi request reprint The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
    Kaberi Dasgupta
    Divisions of General Internal Medicine, Clinical Epidemiology and Endocrinology, Department of Medicine, McGill University, McGill University Health Centre, Montreal, Quebec, Canada Electronic address
    Can J Cardiol 30:485-501. 2014
  9. doi request reprint Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States
    Padma Kaul
    Division of Cardiology, Department of Medicine, University of Alberta, and Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada Electronic address
    JACC Heart Fail 1:523-30. 2013
  10. ncbi request reprint Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF)
    Jonathan G Howlett
    Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada
    Circ Cardiovasc Qual Outcomes 6:534-42. 2013

Detail Information

Publications15

  1. pmc Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials
    Jonathan G Howlett
    University of Calgary, Calgary, Alberta
    Can J Cardiol 25:85-105. 2009
    ....
  2. pmc End-of-life planning in heart failure: it should be the end of the beginning
    Jonathan Howlett
    University of Calgary, Alberta
    Can J Cardiol 26:135-41. 2010
    ..Heart failure is an advanced form of CVD with very high morbidity, mortality and burden of care, making it an ideal condition for implementation and testing of interventions to improve end-of-life planning and care...
  3. ncbi request reprint Nebivolol: vasodilator properties and evidence for relevance in treatment of cardiovascular disease
    Jonathan G Howlett
    Department of Medicine, University of Calgary and Libin Cardiovascular Institute, Calgary, Alberta, Canada Electronic address
    Can J Cardiol 30:S29-37. 2014
    ..These properties position nebivolol as a treatment option for patients with hypertension and/or structural heart disease, although its precise role in the therapeutic armamentarium remains to be clarified. ..
  4. ncbi request reprint Specialist heart failure clinics must evolve to stay relevant
    Jonathan G Howlett
    Department of Cardiac Sciences, University of Calgary and Libin Cardiovascular Institute, Calgary, Alberta, Canada Electronic address
    Can J Cardiol 30:276-80. 2014
    ....
  5. doi request reprint Palliative care in heart failure: addressing the largest care gap
    Jonathan G Howlett
    University of Calgary, 1403 29th Street NW, Calgary, Alberta, Canada
    Curr Opin Cardiol 26:144-8. 2011
    ..Consequently, in comparison to patients with malignancy, heart failure patients at the end of life are less likely to access palliative resources, and more likely to access in-patient care and cardiovascular procedures...
  6. pmc The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs
    Jonathan G Howlett
    University of Calgary, Alberta, Canada
    Can J Cardiol 26:185-202. 2010
    ..Both of these topics were written from a clinical perspective. It is hoped that the present update will become a useful tool for health care providers and planners in the ongoing evolution of care for HF patients in Canada...
  7. doi request reprint The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
    Daniel G Hackam
    Division of Clinical Pharmacology, Department of Medicine, Western University, London, Ontario, Canada
    Can J Cardiol 29:528-42. 2013
    ..However, both of these issues will be examined on an ongoing basis, in particular as new evidence emerges...
  8. ncbi request reprint The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
    Kaberi Dasgupta
    Divisions of General Internal Medicine, Clinical Epidemiology and Endocrinology, Department of Medicine, McGill University, McGill University Health Centre, Montreal, Quebec, Canada Electronic address
    Can J Cardiol 30:485-501. 2014
    ..The Canadian Hypertension Education Program recommendations will continue to be updated annually. ..
  9. doi request reprint Differences in treatment, outcomes, and quality of life among patients with heart failure in Canada and the United States
    Padma Kaul
    Division of Cardiology, Department of Medicine, University of Alberta, and Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada Electronic address
    JACC Heart Fail 1:523-30. 2013
    ..A further aim was to supplement the within-trial analysis with a contemporaneous population-based comparison of all patients hospitalized with primary diagnoses of heart failure (HF) in the 2 countries...
  10. ncbi request reprint Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF)
    Jonathan G Howlett
    Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada
    Circ Cardiovasc Qual Outcomes 6:534-42. 2013
    ..We examined common measures of quality of care in patients enrolled in the international Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure trial...
  11. doi request reprint Acute heart failure: lessons learned so far
    Jonathan G Howlett
    Department of Cardiac Sciences, University of Calgary, and Libin Cardiovascular Institute, Calgary, Alberta, Canada
    Can J Cardiol 27:284-95. 2011
    ..AHF is an important clinical area that has not been as intensively studied as chronic HF; it presents both important needs and exciting opportunities for research and innovation...
  12. pmc A case series of systemic right ventricular dysfunction post atrial switch for simple D-transposition of the great arteries: the impact of beta-blockade
    Colin B Josephson
    Department of Medicine, Dalhousie University, Halifax, Canada
    Can J Cardiol 22:769-72. 2006
    ..Patients with atrial switch (Mustard or Senning) repair of D-transposition of the great arteries (D-TGA) are at increased risk for atrial arrhythmias, systemic right ventricular (RV) dysfunction and late mortality...
  13. ncbi request reprint Acutely decompensated congestive heart failure: new therapies for an old problem
    Jonathan G Howlett
    Department of Medicine, Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia B3H 3A7, Canada
    Expert Rev Cardiovasc Ther 3:925-36. 2005
    ..This is reflected in the relative paucity of guidelines for this condition...
  14. doi request reprint The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy
    Doreen M Rabi
    Department of Medicine, University of Calgary, Calgary, Alberta, Canada
    Can J Cardiol 27:415-433.e1-2. 2011
    ..We also discussed the recent analyses that examined the association between angiotensin II receptor blockers (ARBs) and cancer...
  15. ncbi request reprint Determinants of early readmission after hospitalization for heart failure
    Cathy A Eastwood
    Faculty of Nursing, University of Calgary, Calgary, Alberta, Canada
    Can J Cardiol 30:612-8. 2014
    ..Thus, we studied the characteristics of patients readmitted within 7 and 30 days after hospitalization for HF in Alberta, Canada...